This Biotech Startup Thinks It Can Reverse Vision Loss and Cellular Aging. It’s Testing a Novel Therapy Now
The first human patient has received a dose of Life Biosciences’ sight recovery drug.
The first human patient has received a dose of Life Biosciences’ sight recovery drug.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.